A note from the founders:
Ethan D. Leder and Mark P. Clein
We founded Precision Medicine Group in 2012 because we believed there was a transformational opportunity to improve the process of bringing new drugs to market. It involves utilizing technology, data and human expertise. It is a big challenge that involves diverse talents. Our model involves both nurturing and investing organically and acquiring capabilities that we do not have but critically need. Our core executive team has been following this model for nearly twenty years, building life science service businesses that address fundamental changes in the health care system necessary for improving care and health outcomes.
If you want to learn more or think you could be part of the story,
we would love to talk.